Cite
HARVARD Citation
Shalman, A. et al. (2020). Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS). Journal of clinical neuroscience. pp. 247-249. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shalman, A. et al. (2020). Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS). Journal of clinical neuroscience. pp. 247-249. [Online].